SUVN‐I7016031

N/A

Report date: 2024/10/10 10:04:53
NME

Base Information

Drug NameSUVN‐I7016031
Drug Alias NameSUVN‐I7016031
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionMuscarinic acetylcholine receptor M1 modulators
TargetsMuscarinic acetylcholine receptor M1
Therapy Area/IndicationsParkinson Disease
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesSuven Life Sciences Ltd
China Registration ClassN/A

Develop Information

Active CompaniesSuven Life Sciences Ltd
Inactive CompaniesN/A
Active IndicationsParkinson Disease
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A